Regulation of growth factor receptors by glycosphingolipids

Glycosignals in Cancer: Mechanisms of Malignant Phenotypes

Volumn , Issue , 2016, Pages 77-93

  Handa, Kazuko ^a   Hakomori, Sen Itiroh ^a,b  

^a PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Aberrant glycosylation; Cancer; Cell phenotype; Cell signaling; Glycosphingolipids; Growth factor; Growth factor receptor; Membrane microdomain; Tetraspanin

Indexed keywords

EID: 84960493466     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-4-431-55939-9_5     Document Type: Chapter

References (96)

1. Abercrombie M, Heaysman JE (1954) Observations on the social behaviour of cells in tissue culture. II. Monolayering of fibroblasts. Exp Cell Res 6(2):293–306
2. Bladt F, Riethmacher D, Isenmann S, Aguzzi A, Birchmeier C (1995) Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature 376 (6543):768–771. doi:10.1038/376768a0
3. Bottaro DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Vande Woude GF, Aaronson SA (1991) Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251(4995):802–804
4. Brady RO, Borek C, Bradley RM (1969) Composition and synthesis of gangliosides in rat hepatocyte and hepatoma cell lines. J Biol Chem 244(23):6552–6554
5. Bremer EG, Hakomori S (1982) GM3 ganglioside induces hamster fibroblast growth inhibition in chemically-defined medium: ganglioside may regulate growth factor receptor function. Biochem Biophys Res Commun 106(3):711–718
6. Bremer EG, Hakomori S (1984) Gangliosides as receptor modulators. Adv Exp Med Biol 174:381–394
7. Bremer EG, Hakomori S, Bowen-Pope DF, Raines E, Ross R (1984) Ganglioside-mediated modulation of cell growth, growth factor binding, and receptor phosphorylation. J Biol Chem 259(11):6818–6825
8. Bremer EG, Schlessinger J, Hakomori S (1986) Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor. J Biol Chem 261(5):2434–2440
9. Brown DA, London E (1997) Structure of detergent-resistant membrane domains: does phase separation occur in biological membranes? Biochem Biophys Res Commun 240(1):1–7. doi:10.1006/bbrc.1997.7575
10. Brown DA, London E (2000) Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J Biol Chem 275(23):17221–17224. doi:10.1074/jbc.R000005200
11. Cohen S (1965) The stimulation of epidermal proliferation by a specific protein (EGF). Dev Biol 12:394–407
12. Dohi T, Nores G, Hakomori S (1988) An IgG3 monoclonal antibody established after immunization with GM3 lactone: immunochemical specificity and inhibition of melanoma cell growth in vitro and in vivo. Cancer Res 48(20):5680–5685
13. Furukawa K, Ohmi Y, Ohkawa Y, Tokuda N, Kondo Y, Tajima O, Furukawa K (2011) Regulatory mechanisms of nervous systems with glycosphingolipids. Neurochem Res 36(9):1578–1586. doi:10.1007/s11064-011-0494-2
14. Gherardi E, Gray J, Stoker M, Perryman M, Furlong R (1989) Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement. Proc Natl Acad Sci USA 86(15):5844–5848
15. Gospodarowicz D (1974) Localisation of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth. Nature 249(453):123–127
16. Greene LA, Tischler AS (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 73 (7):2424–2428
17. Hakomori S (1970) Cell density-dependent changes of glycolipid concentrations in fibroblasts, and loss of this response in virus-transformed cells. Proc Natl Acad Sci USA 67(4):1741–1747
18. Hakomori S (1981) Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. Annu Rev Biochem 50:733–764. doi:10.1146/annurev.bi.50.070181.003505
19. Hakomori SI (1983) Sphingolipid biochemistry, vol 3, Handbook of lipid research. Springer, New York. doi:10.1007/978-1-4757-0396-2_1
20. Hakomori S (2002) Glycosylation defining cancer malignancy: new wine in an old bottle. Proc Natl Acad Sci USA 99(16):10231–10233. doi:10.1073/pnas.172380699
21. Hakomori S (2003) Structure, organization, and function of glycosphingolipids in membrane. Curr Opin Hematol 10(1):16–24
22. Hakomori S (2004) Glycosynapses: microdomains controlling carbohydrate-dependent cell adhesion and signaling. An Acad Bras Cienc 76(3):553–572, doi:/S0001-37652004000300010
23. Hakomori SI (2008) Structure and function of glycosphingolipids and sphingolipids: recollections and future trends. Biochim Biophys Acta 1780(3):325–346. doi:10.1016/j.bbagen.2007.08.015
24. Hakomori S, Handa K (2002) Glycosphingolipid-dependent cross-talk between glycosynapses interfacing tumor cells with their host cells: essential basis to define tumor malignancy. FEBS Lett 531(1):88–92
25. Hakomori SI, Murakami WT (1968) Glycolipids of hamster fibroblasts and derived malignanttransformed cell lines. Proc Natl Acad Sci USA 59(1):254–261
26. Hakomori S, Strycharz GD (1968) Investigations on cellular blood-group substances. I. Isolation and chemical composition of blood-group ABH and Le-b isoantigens of sphingoglycolipid nature. Biochemistry 7(4):1279–1286
27. Hakomori SI, Siddiqui B, Li YT, Li SC, Hellerqvist CG (1971) Anomeric structure of globoside and ceramide grihexoside of human erythrocytes and hamster fibroblasts. J Biol Chem 246 (7):2271–2277
28. Hanai N, Nores G, Torres-Mendez CR, Hakomori S (1987) Modified ganglioside as a possible modulator of transmembrane signaling mechanism through growth factor receptors: a preliminary note. Biochem Biophys Res Commun 147(1):127–134
29. Hanai N, Dohi T, Nores GA, Hakomori S (1988a) A novel ganglioside, de-N-acetyl-GM3 (II3NeuNH2LacCer), acting as a strong promoter for epidermal growth factor receptor kinase and as a stimulator for cell growth. J Biol Chem 263(13):6296–6301
30. Hanai N, Nores GA, MacLeod C, Torres-Mendez CR, Hakomori S (1988b) Ganglioside-mediated modulation of cell growth. Specific effects of GM3 and lyso-GM3 in tyrosine phosphorylation of the epidermal growth factor receptor. J Biol Chem 263(22):10915–10921
31. Handa K, Hakomori SI (2012) Carbohydrate to carbohydrate interaction in development process and cancer progression. Glycoconj J 29(8–9):627–637. doi:10.1007/s10719-012-9380-7
32. Hasegawa T, Yamaguchi K, Wada T, Takeda A, Itoyama Y, Miyagi T (2000) Molecular cloning of mouse ganglioside sialidase and its increased expression in Neuro2a cell differentiation. J Biol Chem 275(11):8007–8015
33. Ito J, Kato T, Okumura-Noji K, Miyatani Y, Tanaka R, Tsuji S, Nagai Y (1989) Induction of astroglial growth inhibition and differentiation by sialosyl cholesterol. Brain Res 481 (2):335–343
34. Ito H, Tashiro K, Stroud MR, Orntoft TF, Meldgaard P, Singhal AK, Hakomori S (1992) Specificity and immunobiological properties of monoclonal antibody IMH2, established after immunization with Le(b)/Le(a) glycosphingolipid, a novel extended type 1 chain antigen. Cancer Res 52(13):3739–3745
35. Kabayama K, Sato T, Saito K, Loberto N, Prinetti A, Sonnino S, Kinjo M, Igarashi Y, Inokuchi J (2007) Dissociation of the insulin receptor and caveolin-1 complex by ganglioside GM3 in the state of insulin resistance. Proc Natl Acad Sci USA 104(34):13678–13683
36. Kannagi R, Nudelman E, Levery SB, Hakomori S (1982) A series of human erythrocyte glycosphingolipids reacting to the monoclonal antibody directed to a developmentally regulated antigen SSEA-1. J Biol Chem 257(24):14865–14874
37. Kannagi R, Cochran NA, Ishigami F, Hakomori S, Andrews PW, Knowles BB, Solter D (1983a) Stage-specific embryonic antigens (SSEA-3 and _4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells. EMBO J 2(12):2355–2361
38. Kannagi R, Levery SB, Ishigami F, Hakomori S, Shevinsky LH, Knowles BB, Solter D (1983b) New globoseries glycosphingolipids in human teratocarcinoma reactive with the monoclonal antibody directed to a developmentally regulated antigen, stage-specific embryonic antigen 3. J Biol Chem 258(14):8934–8942
39. Kaucic K, Liu Y, Ladisch S (2006) Modulation of growth factor signaling by gangliosides: positive or negativę Methods Enzymol 417:168–185
40. Kawashima N, Yoon SJ, Itoh K, Nakayama K (2009) Tyrosine kinase activity of epidermal growth factor receptor is regulated by GM3 binding through carbohydrate to carbohydrate interactions. J Biol Chem 284(10):6147–6155. doi:10.1074/jbc.M808171200
41. Kohler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256(5517):495–497
42. Lee L, Abe A, Shayman JA (1999) Improved inhibitors of glucosylceramide synthase. J Biol Chem 274(21):14662–14669
43. Levi-Montalcini R (1987) The nerve growth factor 35 years later. Science 237(4819):1154–1162
44. Levi-Montalcini R, Cohen S (1956) In vitro and in vivo effects of a nerve growth-stimulating agent isolated from snake venom. Proc Natl Acad Sci USA 42(9):695–699
45. Liang YJ, Ding Y, Levery SB, Lobaton M, Handa K, Hakomori SI (2013) Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells. Proc Natl Acad Sci USA 110(13):4968–4973. doi:10.1073/pnas.1302825110
46. Lingwood CA, Hakomori S (1977) Selective inhibition of cell growth and associated changes in glycolipid metabolism induced by monovalent antibodies to glycolipids. Exp Cell Res 108 (2):385–391
47. Liu JW, Sun P, Yan Q, Paller AS, Gerami P, Ho N, Vashi N, Le Poole IC, Wang XQ (2009) De-Nacetyl GM3 promotes melanoma cell migration and invasion through urokinase plasminogen activator receptor signaling-dependent MMP-2 activation. Cancer Res 69(22):8662–8669. doi:10.1158/0008-5472.CAN-09-1099
48. Meuillet EJ, Kroes R, Yamamoto H, Warner TG, Ferrari J, Mania-Farnell B, George D, Rebbaa A, Moskal JR, Bremer EG (1999) Sialidase gene transfection enhances epidermal growth factor receptor activity in an epidermoid carcinoma cell line, A431. Cancer Res 59(1):234–240
49. Miljan EA, Meuillet EJ, Mania-Farnell B, George D, Yamamoto H, Simon HG, Bremer EG (2002) Interaction of the extracellular domain of the epidermal growth factor receptor with gangliosides. J Biol Chem 277(12):10108–10113. doi:10.1074/jbc.M111669200
50. Mitsuda T, Furukawa K, Fukumoto S, Miyazaki H, Urano T, Furukawa K (2002) Overexpression of ganglioside GM1 results in the dispersion of platelet-derived growth factor receptor from glycolipid-enriched microdomains and in the suppression of cell growth signals. J Biol Chem 277(13):11239–11246
51. Mitsuzuka K, Handa K, Satoh M, Arai Y, Hakomori S (2005) A specific microdomain (“glycosynapse 3”) controls phenotypic conversion and reversion of bladder cancer cells through GM3-mediated interaction of alpha3beta1 integrin with CD9. J Biol Chem 280 (42):35545–35553. doi:10.1074/jbc.M505630200
52. Miura Y, Kainuma M, Jiang H, Velasco H, Vogt PK, Hakomori S (2004) Reversion of the Jun-induced oncogenic phenotype by enhanced synthesis of sialosyllactosylceramide (GM3 ganglioside). Proc Natl Acad Sci USA 101(46):16204–16209. doi:10.1073/pnas.0407297101
53. Miyata M, Kambe M, Tajima O, Moriya S, Sawaki H, Hotta H, Kondo Y, Narimatsu H, Miyagi T, Furukawa K, Furukawa K (2011) Membrane sialidase NEU3 is highly expressed in human melanoma cells promoting cell growth with minimal changes in the composition of gangliosides. Cancer Sci 102(12):2139–2149. doi:10.1111/j.1349-7006.2011.02086.x
54. Mora PT, Brady RO, Bradley RM, McFarland VW (1969) Gangliosides in DNA virus-transformed and spontaneously transformed tumorigenic mouse cell lines. Proc Natl Acad Sci USA 63 (4):1290–1296
55. Mutoh T, Tokuda A, Guroff G, Fujiki N (1993) The effect of the B subunit of cholera toxin on the action of nerve growth factor on PC12 cells. J Neurochem 60(4):1540–1547
56. Mutoh T, Tokuda A, Miyadai T, Hamaguchi M, Fujiki N (1995) Ganglioside GM1 binds to the Trk protein and regulates receptor function. Proc Natl Acad Sci USA 92(11):5087–5091
57. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K, Shimizu S (1989) Molecular cloning and expression of human hepatocyte growth factor. Nature 342 (6248):440–443. doi:10.1038/342440a0
58. Nojiri H, Takaku F, Terui Y, Miura Y, Saito M (1986) Ganglioside GM3: an acidic membrane component that increases during macrophage-like cell differentiation can induce monocytic differentiation of human myeloid and monocytoid leukemic cell lines HL-60 and U937. Proc Natl Acad Sci USA 83(3):782–786
59. Nojiri H, Kitagawa S, Nakamura M, Kirito K, Enomoto Y, Saito M (1988) Neolacto-series gangliosides induce granulocytic differentiation of human promyelocytic leukemia cell line HL-60. J Biol Chem 263(16):7443–7446
60. Nores GA, Hanai N, Levery SB, Eaton HL, Salyan EK, Hakomori S (1988) Synthesis and characterization of lyso-GM3 (II3Neu5Ac Lactosyl sphingosine), de-N-acetyl-GM3 (II3NeuNH2 lactosyl Cer), and related compounds. Carbohydr Res 179:393–410
61. Nores GA, Hanai N, Levery SB, Eaton HL, Salyan ME, Hakomori S (1989) Synthesis and characterization of ganglioside GM3 derivatives: lyso-GM3, de-N-acetyl-GM3, and other compounds. Methods Enzymol 179:242–253
62. Nudelman ED, Levery SB, Igarashi Y, Hakomori S (1992) Plasmalopsychosine, a novel plasmal (fatty aldehyde) conjugate of psychosine with cyclic acetal linkage. Isolation and characterization from human brain white matter. J Biol Chem 267(16):11007–11016
63. Ono M, Handa K, Sonnino S, Withers DA, Nagai H, Hakomori S (2001) GM3 ganglioside inhibits CD9-facilitated haptotactic cell motility: coexpression of GM3 and CD9 is essential in the downregulation of tumor cell motility and malignancy. Biochemistry 40(21):6414–6421
64. Papini N, Anastasia L, Tringali C, Croci G, Bresciani R, Yamaguchi K, Miyagi T, Preti A, Prinetti A, Prioni S, Sonnino S, Tettamanti G, Venerando B, Monti E (2004) The plasma membrane-associated sialidase MmNEU3 modifies the ganglioside pattern of adjacent cells supporting its involvement in cell-to-cell interactions. J Biol Chem 279(17):16989–16995. doi:10.1074/jbc.M400881200
65. Park M, Dean M, Kaul K, Braun MJ, Gonda MA, Vande Woude G (1987) Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proc Natl Acad Sci USA 84(18):6379–6383
66. Paul D, Lipton A, Klinger I (1971) Serum factor requirements of normal and simian virus 40-transformed 3T3 mouse fibroplasts. Proc Natl Acad Sci USA 68(3):645–652
67. Proia RL (2003) Glycosphingolipid functions: insights from engineered mouse models. Philos Trans R Soc Lond B Biol Sci 358(1433):879–883. doi:10.1098/rstb.2003.1268
68. Radin NS, Shayman JA, Inokuchi J (1993) Metabolic effects of inhibiting glucosylceramide synthesis with PDMP and other substances. Adv Lipid Res 26:183–213
69. Robbins PW, Macpherson I (1971) Control of glycolipid synthesis in a cultured hamster cell line. Nature 229(5286):569–570
70. Rong S, Segal S, Anver M, Resau JH, Vande Woude GF (1994) Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc Natl Acad Sci USA 91(11):4731–4735
71. Sakakura C, Igarashi Y, Anand JK, Sadozai KK, Hakomori S (1996) Plasmalopsychosine of human brain mimics the effect of nerve growth factor by activating its receptor kinase and mitogen-activated protein kinase in PC12 cells. Induction of neurite outgrowth and prevention of apoptosis. J Biol Chem 271(2):946–952
72. Sakiyama H, Gross SK, Robbins PW (1972) Glycolipid synthesis in normal and virus-transformed hamster cell lines. Proc Natl Acad Sci USA 69(4):872–876
73. Shiozaki K, Yamaguchi K, Sato I, Miyagi T (2009) Plasma membrane-associated sialidase (NEU3) promotes formation of colonic aberrant crypt foci in azoxymethane-treated transgenic mice. Cancer Sci 100(4):588–594. doi:10.1111/j.1349-7006.2008.01080.x
74. Simons K, Ikonen E (1997) Functional rafts in cell membranes. Nature 387(6633):569–572. doi:10.1038/42408
75. Sonnino S, Prinetti A (2010) Gangliosides as regulators of cell membrane organization and functions. Adv Exp Med Biol 688:165–184
76. Stan RV, Roberts WG, Predescu D, Ihida K, Saucan L, Ghitescu L, Palade GE (1997) Immunoisolation and partial characterization of endothelial plasmalemmal vesicles (caveolae). Mol Biol Cell 8(4):595–605
77. Stroud MR, Levery SB, Nudelman ED, Salyan ME, Towell JA, Roberts CE, Watanabe M, Hakomori S (1991) Extended type 1 chain glycosphingolipids: dimeric Lea (III4V4Fuc2Lc6) as human tumor-associated antigen. J Biol Chem 266(13):8439–8446
78. Stroud MR, Levery SB, Salyan ME, Roberts CE, Hakomori S (1992) Extended type-1 chain glycosphingolipid antigens. Isolation and characterization of trifucosyl-Leb antigen (III4V4VI2Fuc3Lc6). Eur J Biochem/FEBS 203(3):577–586
79. Taniguchi N, Honke K, Fukuda M (2002) Handbook of glycosyltransferases and related genes. Springer, Tokyo/New York
80. Tettamanti G, Bonali F, Marchesini S, Zambotti V (1973) A new procedure for the extraction, purification and fractionation of brain gangliosides. Biochim Biophys Acta 296(1):160–170
81. Todeschini AR, Dos Santos JN, Handa K, Hakomori SI (2007) Ganglioside GM2-tetraspanin CD82 complex inhibits met and its cross-talk with integrins, providing a basis for control of cell motility through glycosynapse. J Biol Chem 282(11):8123–8133. doi:10.1074/jbc.M611407200
82. Todeschini AR, Dos Santos JN, Handa K, Hakomori SI (2008) Ganglioside GM2/GM3 complex affixed on silica nanospheres strongly inhibits cell motility through CD82/cMet-mediated pathway. Proc Natl Acad Sci USA 105(6):1925–1930. doi:10.1073/pnas.0709619104
83. Toledo MS, Suzuki E, Handa K, Hakomori S (2004) Cell growth regulation through GM3-enriched microdomain (glycosynapse) in human lung embryonal fibroblast WI38 and its oncogenic transformant VA13. J Biol Chem 279(33):34655–34664. doi:10.1074/jbc.M403857200
84. Toledo MS, Suzuki E, Handa K, Hakomori S (2005) Effect of ganglioside and tetraspanins in microdomains on interaction of integrins with fibroblast growth factor receptor. J Biol Chem 280(16):16227–16234. doi:10.1074/jbc.M413713200
85. Ullrich A, Schlessinger J (1990) Signal transduction by receptors with tyrosine kinase activity. Cell 61(2):203–212
86. Veracini L, Simon V, Richard V, Schraven B, Horejsi V, Roche S, Benistant C (2008) The Csk-binding protein PAG regulates PDGF-induced Src mitogenic signaling via GM1. J Cell Biol 182(3):603–614
87. Wada T, Hata K, Yamaguchi K, Shiozaki K, Koseki K, Moriya S, Miyagi T (2007) A crucial role of plasma membrane-associated sialidase in the survival of human cancer cells. Oncogene 26 (17):2483–2490. doi:10.1038/sj.onc.1210341
88. Watanabe M, Ohishi T, Kuzuoka M, Nudelman ED, Stroud MR, Kubota T, Kodairo S, Abe O, Hirohashi S, Shimosato Y et al (1991) In vitro and in vivo antitumor effects of murine monoclonal antibody NCC-ST-421 reacting with dimeric Le(a) (Le(a)/Le(a)) epitope. Cancer Res 51(8):2199–2204
89. Weis FM, Davis RJ (1990) Regulation of epidermal growth factor receptor signal transduction. Role of gangliosides. J Biol Chem 265(20):12059–12066
90. Wiegandt H (1985) Glycolipids. New comprehensive biochemistry, vol 10. Elsevier, Amsterdam/New York
91. Yang HJ, Hakomori SI (1971) A sphingolipid having a novel type of ceramide and lacto-Nfucopentaose 3. J Biol Chem 246(5):1192–1200
92. Yarden Y, Ullrich A (1988) Growth factor receptor tyrosine kinases. Annu Rev Biochem 57:443–478. doi:10.1146/annurev.bi.57.070188.002303
93. Yates AJ, Rampersaud A (1998) Sphingolipids as receptor modulators. An overview. Ann NY Acad Sci 845:57–71
94. Yoon SJ, Nakayama K, Hikita T, Handa K, Hakomori SI (2006) Epidermal growth factor receptor tyrosine kinase is modulated by GM3 interaction with N-linked GlcNAc termini of the receptor. Proc Natl Acad Sci USA 103(50):18987–18991. doi:10.1073/pnas.0609281103
95. Yu RK, Tsai YT, Ariga T (2012) Functional roles of gangliosides in neurodevelopment: an overview of recent advances. Neurochem Res 37(6):1230–1244. doi:10.1007/s11064-012-0744-y
96. Zhou Q, Hakomori S, Kitamura K, Igarashi Y (1994) GM3 directly inhibits tyrosine phosphorylation and de-N-acetyl-GM3 directly enhances serine phosphorylation of epidermal growth factor receptor, independently of receptor-receptor interaction. J Biol Chem 269(3):1959–1965